{"ORPHApacket":[{"ORPHApacketID":"213777","date":"2019-12-06 00:22:57","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"213777","Name":[{"lang":"en","label":"High-grade neuroendocrine carcinoma of the cervix uteri"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_213777","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Neuroendocrine tumor with other location"}],"ORPHA":"100101","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_100101"},{"Name":[{"lang":"en","label":"Rare cancer of cervix uteri"}],"ORPHA":"213761","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_213761"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"High-grade neuroendocrine carcinoma of the cervix uteri is a rare, aggressive, primary cervical neoplasm, originating from neuroendocrine cells present in the lining epithelium of the cervix, characterized, macroscopically, by usually large lesions, sometimes with a barrel-shaped appearance. Patients often present with abnormal vaginal bleeding or discharge, pelvic\/abdominal pain, post-coital spotting and\/or dysuria, while symptoms related to carcinoid syndrome are not frequent."}],"AverageAgeOfOnsetList":[{"count":"2","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"Adult"}]},{"Name":[{"lang":"en","label":"Elderly"}]}]}],"SynonymList":[{"count":"3","Synonym":[{"lang":"en","label":"High-grade neuroendocrine carcinoma of the uterine cervix"},{"lang":"en","label":"Poorly differentiated neuroendocrine carcinoma of the cervix uteri"},{"lang":"en","label":"Poorly differentiated neuroendocrine cervical carcinoma"}]}]}]}